by Sue Robbins | Nov 17, 2020 | Migraine
Nearly 80% of people taking a new class of medication to prevent migraine say their migraine headaches are “better” since they started taking the drugs, according to a survey conducted by Eli Lilly. Calcitonin gene-related peptide (CGRP) inhibitors prevent migraines...
by Sue Robbins | Nov 10, 2020 | Migraine
Many people who get migraines experience worsening symptoms during extreme weather changes, hot or humid summer weather, or changes in barometric pressure. Several studies attempting to find a scientific correlation between weather and migraines have yielded...
by Sue Robbins | Nov 2, 2020 | Migraine
Treatment with fremanezumab, the fully humanized IgG2?a monoclonal antibody that selectively targets calcitonin gene-related peptide, significantly reduced the number of headache or migraine days experienced before therapy. These findings, from a pooled analysis of...
by Sue Robbins | Oct 20, 2020 | Migraine
A migraine is a neurovascular condition that is described as a debilitating and recurring headache. It is often accompanied by vomiting and some sensory sensitivities. It has been reported that 20% of the people who have migraines turn to prescription medication for...
by Sue Robbins | Oct 18, 2020 | Migraine
Sleep Predicts Migraine Recurrence — Sleep quality may identify patients at risk of developing chronic migraine Sleep quality at a single time point was tied to headaches occurring over the next 6 weeks among people with episodic migraine, a prospective study...
by Sue Robbins | Oct 12, 2020 | Migraine
Protective parenting behavior is associated with significantly greater frequency of adolescent headaches, according to study results published in Headache. Previous studies have shown that adolescent pain severity and pain-related disability are greater when parents...
